Neuropsychiatric Inventory (NPI): Dementia Assessment
The Neuropsychiatric Inventory evaluates behavioural symptoms in dementia through caregiver interviews. It helps clinicians track changes like agitation to guide treatment decisions.
Neuropsychiatric Inventory (NPI)
The Neuropsychiatric Inventory (NPI) assesses behavioural changes in dementia patients. By interviewing caregivers, it evaluates symptoms like agitation and depression. It's an essential tool for clinicians to accurately track disease progression and treatment effects.
Category
Disease
Source
What is Neuropsychiatric Inventory (NPI)
The Neuropsychiatric Inventory (NPI) is a widely used tool for assessing dementia-related behaviours. It helps clinicians track changes over time. This assessment relies on a structured interview with a caregiver who knows the patient well. It looks at twelve distinct behavioural areas that are common in dementia cases. The tool covers symptoms like agitation, apathy, and hallucinations. For each area, the caregiver rates how often it happens and how severe it is. They also rate their own distress levels, which gives a full picture of the burden involved. It usually takes about ten to twenty minutes to finish, making it practical for busy clinics. Doctors use the scores to see if medications or therapies are working effectively. By spotting specific issues early, care teams can adjust their plans to support both the patient and the family better.
The Neuropsychiatric Inventory can be scored using two main approaches: Symptom Severity and Caregiver Distress. 1. Symptom Severity: For each behavioural domain, multiply the frequency (1 to 4) by the severity (1 to 3). This produces a domain score up to 12. Sum these across all 12 domains for a total between 0 and 144 to measure overall symptom load. 2. Caregiver Distress: Carers rate their emotional stress for each symptom from 0 (none) to 5 (extreme). This separate score helps teams identify carer burnout risks.
Advantages
.svg){kind=icon}
Tracks patient condition changes systematically.
Develops personalised strategies based on assessment data.
.svg){kind=icon}
Applicable across multiple diseases and conditions.
.svg){kind=icon}
Measures treatment effectiveness through standardised tools.
.png){kind=icon}
Related Instruments
Screens for neuropathic pain components.
Predicts long-term disability risk in musculoskeletal pain.
Assesses symptoms and function in lumbar spinal stenosis.
Collect Neuropsychiatric Inventory data with WeGuide, the all in one platform
Support Your patient in no time - all under your own brand
Our platform combines the knowledge of 100+ digital health solutions built, letting you easily build your patient engagement app for research or clinical use. Collect PROMs, support patients on waiting lists, or gather vital signs data. This is how:
Learn More.png){kind=icon}
Program Builder
.png)
.png){kind=icon}
Whitelabelling
.svg)
.svg)
.png){kind=icon}
Turn on components, dependent on your usecase
.svg)
.png){kind=icon}
Support The Full Journey
.png)
.png)
%20(1).png)
.png)
It’s your turn
Every WeGuide project, saves researchers and clinicians - 9 months and $450,000 - creating impactful digital health solutions.
